| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |